Downregulation of Claudin5 promotes malignant progression and radioresistance through Beclin1-mediated autophagy in esophageal squamous cell carcinoma.
Shan HuangJiayi ZhangYi LiYaqiong XuHui JiaLei AnXiaotan WangYuting YangPublished in: Journal of translational medicine (2023)
In summary, these findings suggest that downregulation of Claudin5 promotes ESCC malignant progression and radioresistance via Beclin1-autophagy activation and may serve as a promising biomarker for predicting radiotherapy response and patient outcome in ESCC.